
Opinion|Videos|August 8, 2024
Addressing Knowledge Gaps and Treatment Strategies in Bronchiectasis
Author(s)Panagis Galiatsatos, MD
A pulmonary specialist shares his approach to treating patients with bronchiectasis, highlighting gaps in knowledge that impact management practices.
Advertisement
Video content above is prompted by the following questions:
- What are the current gaps in knowledge regarding the management of bronchiectasis?
- What is your typical treatment approach to managing bronchiectasis?
- What patient-specific factors impact your approach to treatment?
- How can comorbid disease impact the management of bronchiectasis?
- How do you approach the treatment of specific infections (e.g., Pseudomonas aeruginosa)?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
ERS Posters Showcase Nerandomilast Benefits in IPF, ILD
5